GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Magellan Health Inc (NAS:MGLN) » Definitions » Piotroski F-Score

Magellan Health (Magellan Health) Piotroski F-Score : 6 (As of Apr. 26, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Magellan Health Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Magellan Health has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Magellan Health's Piotroski F-Score or its related term are showing as below:

MGLN' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 6   Max: 8
Current: 6

During the past 13 years, the highest Piotroski F-Score of Magellan Health was 8. The lowest was 2. And the median was 6.


Magellan Health Piotroski F-Score Historical Data

The historical data trend for Magellan Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magellan Health Piotroski F-Score Chart

Magellan Health Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 6.00 6.00 7.00 6.00

Magellan Health Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 6.00 5.00 6.00 6.00

Competitive Comparison of Magellan Health's Piotroski F-Score

For the Healthcare Plans subindustry, Magellan Health's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Magellan Health's Piotroski F-Score Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Magellan Health's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Magellan Health's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep21) TTM:Last Year (Sep20) TTM:
Net Income was 268.933 + 27.827 + -0.666 + 0.903 = $297 Mil.
Cash Flow from Operations was 396.609 + -77.875 + -64.81 + 202.741 = $457 Mil.
Revenue was 1184.96 + 1161.649 + 1220.768 + 1254.118 = $4,821 Mil.
Gross Profit was 3.941 + 59.067 + 25.946 + 32.002 = $121 Mil.
Average Total Assets from the begining of this year (Sep20)
to the end of this year (Sep21) was
(3381.02 + 3359.855 + 3236.507 + 3217.929 + 3353.45) / 5 = $3309.7522 Mil.
Total Assets at the begining of this year (Sep20) was $3,381 Mil.
Long-Term Debt & Capital Lease Obligation was $516 Mil.
Total Current Assets was $2,204 Mil.
Total Current Liabilities was $756 Mil.
Net Income was 20.584 + 18.25 + 83.505 + 11.647 = $134 Mil.

Revenue was 1133.775 + 1122.379 + 1100.075 + 1170.117 = $4,526 Mil.
Gross Profit was 50.423 + 35.789 + 50.421 + 28.64 = $165 Mil.
Average Total Assets from the begining of last year (Sep19)
to the end of last year (Sep20) was
(3141.721 + 3092.173 + 3224.911 + 3351.203 + 3381.02) / 5 = $3238.2056 Mil.
Total Assets at the begining of last year (Sep19) was $3,142 Mil.
Long-Term Debt & Capital Lease Obligation was $637 Mil.
Total Current Assets was $2,291 Mil.
Total Current Liabilities was $1,101 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Magellan Health's current Net Income (TTM) was 297. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Magellan Health's current Cash Flow from Operations (TTM) was 457. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep20)
=296.997/3381.02
=0.08784243

ROA (Last Year)=Net Income/Total Assets (Sep19)
=133.986/3141.721
=0.04264733

Magellan Health's return on assets of this year was 0.08784243. Magellan Health's return on assets of last year was 0.04264733. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Magellan Health's current Net Income (TTM) was 297. Magellan Health's current Cash Flow from Operations (TTM) was 457. ==> 457 > 297 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep21)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep20 to Sep21
=516.368/3309.7522
=0.1560141

Gearing (Last Year: Sep20)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep19 to Sep20
=637.093/3238.2056
=0.1967426

Magellan Health's gearing of this year was 0.1560141. Magellan Health's gearing of last year was 0.1967426. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep21)=Total Current Assets/Total Current Liabilities
=2204.419/756.019
=2.91582487

Current Ratio (Last Year: Sep20)=Total Current Assets/Total Current Liabilities
=2291.23/1100.879
=2.08127324

Magellan Health's current ratio of this year was 2.91582487. Magellan Health's current ratio of last year was 2.08127324. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Magellan Health's number of shares in issue this year was 26.247. Magellan Health's number of shares in issue last year was 25.448. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=120.956/4821.495
=0.02508682

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=165.273/4526.346
=0.03651356

Magellan Health's gross margin of this year was 0.02508682. Magellan Health's gross margin of last year was 0.03651356. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep20)
=4821.495/3381.02
=1.42604746

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep19)
=4526.346/3141.721
=1.44072182

Magellan Health's asset turnover of this year was 1.42604746. Magellan Health's asset turnover of last year was 1.44072182. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+1+0+0+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Magellan Health has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Magellan Health  (NAS:MGLN) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Magellan Health Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Magellan Health's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Magellan Health (Magellan Health) Business Description

Traded in Other Exchanges
N/A
Address
4801 E. Washington Street, Suite 4400, Phoenix, AZ, USA, 85034
Magellan Health provides healthcare management services to health plans and other managed care organizations, employers, labor unions, United States government agencies, and third-party administrators. The firm operates in three segments: Healthcare, Pharmacy Management, and Corporate. The Healthcare business manages behavioral healthcare services and employee assistance program services, as well as specialty areas like diagnostic imaging. The Pharmacy Management segment includes pharmacy benefit management (PBM) services, pharmacy benefit administration for Medicaid and other government-sponsored programs, pharmaceutical dispensing operations, and clinical and formulary management programs. The Healthcare business generates the majority of revenue.
Executives
Mostafa Kamal officer: CEO, Magellan Rx Management 15950 NORTH 76TH STREET, #200 SCOTTSDALE AZ 85260
Jeffrey N West officer: SVP & Controller 6950 COLUMBIA GATEWAY DR STE 400 COLUMBIA MD 21046
David Bourdon officer: Chief Financial Officer 6303 COWBOYS WAY, SUITE 350, FRISCO TX 75034
Peter A Feld director 201 E LAS OLAS BOULEVARD, SUITE 1000, FORT LAUDERDALE FL 33301
Swati Bargotra Abbott director 4800 NORTH SCOTTSDALE ROAD, SUITE 4400, SCOTTSDALE AZ 85251
Steven J Shulman director 1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329
Guy P Sansone director C/O MEDNAX, 1301 CONCORD TERRACE, SUNRISE FL 33323
Gregory Scott Mackenzie director NDC PLAZA ATLANTA GA 30329
Leslie V Norwalk director C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
Christopher J Chen director 4801 EAST WASHINGTON STREET PHOENIX AZ 85034
Mural R Josephson director
James E Murray officer: President and COO 500 WEST MAIN STREET, LOUISVILLE KY 40202
Clapper Caskie Lewis officer: Chief Human Resources Officer 55 NOD ROAD AVON CT 06001
Kenneth J Fasola director, officer: Chief Executive Officer 500 WEST MAIN STREET, LOUISVILLE KY 40202
Jonathan N Rubin officer: Chief Financial Officer 55 NOD ROAD AVON CT 06001

Magellan Health (Magellan Health) Headlines

From GuruFocus

Magellan Healthcare Launches eMbolden Resilience Program

By Business Wire Business Wire 08-18-2021

Glazer Capital, Llc Buys , , Magellan Health Inc, Sells , , HMS Holdings Corp

By GuruFocus Research GuruFocus Editor 08-17-2021